Canadian government acknowledges patent protection for Cipro
Bayer has agreed to supply one million CIPRO tablets to the National Emergency Stockpile System (NESS) within 48 hours on demand. The Canadian health authorities respect the existing patent rights for CIPRO and have undertaken to acquire the antibiotic ciprofloxacin exclusively from Bayer during the period of patent protection.
Furthermore, a team of experts will be assembled to rapidly and efficiently organize future supplies of ciprofloxacin for emergency use.
Other news from the department research and development
Get the chemical industry in your inbox
From now on, don't miss a thing: Our newsletter for the chemical industry, analytics, lab technology and process engineering brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.